Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06541899Phase 4Completed

Safety and Efficacy of Cryolipolysis Clinical Protocols

Role: lead

NCT04885101Not ApplicableUnknown

Comparison of Conservative Treatment Options in the Management of Erectile Dysfunction

Role: collaborator

NCT05020054Not ApplicableCompleted

Effect of Tecartherapy in the Treatment of Localized Fat and Sagging Abdominal Skin - Clinical and Experimental Study

Role: lead

NCT05017636Not ApplicableCompleted

Effect of Shock Wave Therapy Without Biological and Immuno-histochemical Analysis.

Role: lead

NCT05012514Not ApplicableCompleted

Effects of Led Photobiomodulation Therapy

Role: lead

NCT03275259Not ApplicableCompleted

Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat

Role: lead

NCT03312946Not ApplicableUnknown

Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite.

Role: lead

NCT03199781Not ApplicableUnknown

Motorized Mechanical Massage Associated With Cosmetics in Improving Body Contour and Appearance of Gynoid Lipodystrophy

Role: lead

All 8 trials loaded